Skip to content
Open access

Integrated metagenomic and metabolomic analysis identifies severity-specific inflammatory and metabolic signatures in post-stroke depression

Sep 2026 · Gut microbes · Vol 18 · 0 citations · 45 references
Medicine

TL;DR

Multi-omics clues suggesting associations between different PSD severity levels and features such as increased Alistipes abundance, reduced antioxidant capacity, and altered tryptophan metabolism are provided, but still require validation in larger samples, longitudinal cohorts, and mechanistic studies.

Abstract

ABSTRACT Post-stroke depression (PSD) is a common complication that significantly impacts patient prognosis. This study aimed to systematically characterize the associations among gut microbial ecology, metabolic profiles, and inflammatory responses across different severities of PSD. We conducted metagenomic sequencing, non-targeted metabolomics, and serum cytokine analysis (IL-1β, IL-6, IL-10, IL-18, TNF-α, IFN-γ, and CRP) in 91 patients with varying degrees of PSD and non-PSD controls. Bioinformatics analyzes were employed to construct multi-omics association networks and machine learning models. Results indicated that PSD patients exhibited significantly increased gut microbiota alpha-diversity, suggesting dysbiosis. Mild depression was characterized by compensatory neural signaling activation, whereas the moderate depression group exhibited abnormalities in tryptophan/indole metabolism, oxidative stress-related metabolic imbalances, and functional decompensation. Further analyzes suggested that Alistipes, Blautia_A, Evtepia gabavorous, and Lachnospira were associated with inflammatory features, GABA-related metabolic alterations, aromatic amino acid/indole metabolism, and lipid-amino acid metabolism, respectively. Under a more rigorous 10-fold cross-validation framework, the performance of different multi-omics combination models showed heterogeneity; however, some combinations still demonstrated superior discriminatory ability compared to single-omics approaches. This study provides multi-omics clues suggesting associations between different PSD severity levels and features such as increased Alistipes abundance, reduced antioxidant capacity, and altered tryptophan metabolism. It provides candidate biomarker combinations that may be useful for PSD stratification and suggests that the gut microbiome may represent a potential target for future PSD intervention. In summary, PSD may be associated with dynamic alterations along the “gut–brain-inflammation-metabolism” axis. These findings provide integrated evidence for microbial, metabolic, and inflammatory abnormalities across different PSD severity levels, but still require validation in larger samples, longitudinal cohorts, and mechanistic studies.

Read PDF

Similar papers

Open access Aug 2026

Integrated multi-omics profiling identifies a convergent gut-metabolic-immune signature in Alzheimer's disease.

These findings define a convergent gut-metabolic-immune axis in AD where systemic oxidative stress serves as a central hub, providing specific, measurable redox biomarkers and mechanistic insights for noninvasive screening and therapeutic targeting.

Zong-Xin Ling, Xiao-Cui Xu, Yi-Wen Cheng et al. · 1 citation
Open access Sep 2026

231. Multi-omic longitudinal profiling reveals functional and metabolic gut microbiota signatures predictive of antidepressant response in first episode, drug-naïve depression

The authors' multi-omic longitudinal findings show that antidepressant response reflects not broad diversity shifts but coordinated, fine-scale taxonomic remodeling and metabolite recovery, supporting a dynamic gut–brain–metabolite axis that shapes treatment outcomes and support microbiota-informed, metabolite-targeted...

S. Lin, P.-H. Kuo, S.-S. Huang et al. · 0 citations
Open access Aug 2026

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosis

Findings highlight coordinated dysregulation of amino acid and lipoprotein metabolism as hallmarks of established MS and identify a novel association of the omega-6/omega-3 ratio with inflammatory disease activity.

Rachel E. Rodin, B. Healy, Mariann Polgár-Turcsányi et al. · 0 citations
Open access Sep 2026

Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study

This exploratory study integrates pilot-scale metabolomics with genetic analyses to identify candidate metabolic signals and inflammatory pathways linked to PD and indicated that SULT1A1 may partially mediate the association between 3-phenylpropionylglycine and PD.

Yue Lang, Hui Zhang, Rui Feng et al. · 0 citations
Open access Sep 2026

Integrated proteomic and metabolomic analyses define the molecular architecture of acute mountain sickness

A multi-layer molecular framework of human acute hypoxic stress is defined, linking vascular regulation, inflammation, coagulation, metabolic remodeling, tissue origin, and biomarker prioritization in hypoxia-associated systemic diseases.

Wen-Jing Ding, Yi-Fan Yang, Hua-Ying Wei et al. · 0 citations
Open access Sep 2026

Peripheral neurotransmitter metabolic signatures in schizophrenia: a targeted metabolomics study

The four-metabolite panel (α-ketoglutarate, succinic acid, tryptamine, and amino butyric acid) may provide experimental basis for further mechanistic research and therapeutic development and offer peripheral evidence supporting the core position of GABAergic dysfunction in schizophrenia.

Bing Han, Yu Guo, Baie Feng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.